Cargando…
Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder
Changes in gene expression (GE) during antidepressant treatment may increase understanding of the action of antidepressant medications and serve as biomarkers of efficacy. GE changes in peripheral blood are desirable because they can be assessed easily on multiple occasions during treatment. We repo...
Autores principales: | Cook, Ian A., Congdon, Eliza, Krantz, David E., Hunter, Aimee M., Coppola, Giovanni, Hamilton, Steven P., Leuchter, Andrew F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760033/ https://www.ncbi.nlm.nih.gov/pubmed/31620172 http://dx.doi.org/10.3389/fgene.2019.00870 |
Ejemplares similares
-
Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2014) -
Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder
por: Hunter, Aimee M., et al.
Publicado: (2019) -
The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder
por: Leuchter, Andrew F., et al.
Publicado: (2013) -
Resting-State Quantitative Electroencephalography Reveals Increased Neurophysiologic Connectivity in Depression
por: Leuchter, Andrew F., et al.
Publicado: (2012) -
QEEG Measures in Huntington's Disease: A Pilot Study
por: Hunter, Aimee, et al.
Publicado: (2010)